With excellent basic research and the highest level of scientific and technical infrastructure, develops innovative approaches for personalized diagnosis, therapy, and prevention. HMGU will contribute to the overall BOW project goals with the expertise acquired in a long history in the field of (nano)-particle toxicology with a proven track record and EU-funding. Specifically, HMGU will carry out the i) pre-screening characterization and in vitro nanotoxicology ii) In vivo characterization of BOW products in mice.

HMGU will contribute to the overall BOW project goals with the expertise acquired in a long history in the field of (nano)-particle toxicology with a proven track record and EU-funding. Specifically, HMGU will carry out the i) pre-screening characterization and in vitro nanotoxicology ii) In vivo characterization of BOW products in mice.

Comprehensive Molecular Analysis (CMA) and the partnering chair of analytical chemistry at University of Rostock (Rostock, Germany) jointly conduct research on adverse health effects of (nano)particles, fibers and aerosols.

The Institute of Lung Biology and Disease aims to achieve a mechanistic understanding of disease initiation and progression and aims to develop and harness novel therapeutic strategies, including nanotechnological approaches.